INFLUENCER: Think Botox in a pep INFLUENCER: What we have here is basically exercise in a pill
The Source: The information for this story was provided by the National Institutes of Health and the study titled: A brain reward circuit inhibited by next-generation weight-loss drugs in mice, published May 6, 2026 in Nature
Depression and mood changes, though not commonly reported with GLP-1 receptor agonists, should be considered in the differential diagnosis of fatigue
This process supports the bodys ability to rely more on fat metabolism during prolonged exercise
*Correspondence: Bin Cong, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Diabetes Care, 39 , 152782